SCHEMBL8078419

SCHEMBL8078419

CN(C)c1ncnc(Cl)c1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA13 Q8N1Q1 1/20 0.40
HTT P42858 3/20 0.37
CUL4A Q13619 1/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
TSHR P16473 2/20 0.34
GAA P10253 1/20 0.34
CHEK1 O14757 1/20 0.33
AURKA O14965 1/20 0.33
PDPK1 O15530 1/20 0.33
CHEK2 O96017 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
PRKACA P17612 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9124007 0.81 ALDH1A1 (0.40) LMNACA1CA2CA7CA13
SCHEMBL304909 0.80 CA1 (0.49) LMNACA1CA2CA7CA13
SCHEMBL14805351 0.80 LMNA (0.41) LMNAHTTALDH1A1MAPTMEN1
SCHEMBL2542634 0.80 LMNA (0.43) LMNACA1CA2CA7CA13
SCHEMBL5244451 0.80 MAPT (0.58) LMNAHTTALDH1A1MAPTMEN1
SCHEMBL5247652 0.79 MAPT (0.47) LMNACA1CA2CA7CA13
SCHEMBL9123271 0.78 LMNA (0.49) LMNACA1CA2CA7CA13
SCHEMBL5244192 0.78 MAPT (0.43) LMNACA1CA2CA7CA13
SCHEMBL12459324 0.77 LMNA (0.73) LMNAHTTALDH1A1MAPTMEN1
SCHEMBL13866827 0.76 ALDH1A1 (0.40) LMNACA1CA2CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116535394-A Carbon nitrogen bond diazole energetic compound with polynitro modification or usable salt thereof and preparation method thereof 北京理工大学 2023-08-04 CN disclosed
US-7524847-B2 Fused 1,3-dihydro-imidazole ring compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-04-28 US disclosed
US-6025489-A Tricyclic pteridinones and a process for their preparation SCHERING AKTIENGESELLSCHAFT (DE) 2000-02-15 US disclosed
EP-0429149-B1 Tricyclic pteridinones and a process for their preparation BERLEX LAB (US) 2000-01-05 EP disclosed
US-5854419-A Tricyclic pteridinones and a process for their preparation SCHERING AKTIENGESELLSCHAFT (DE) 1998-12-29 US disclosed
US-5668136-A ANTIARTERIOSCLEROTIC AGENT, CHOLESTEROL O-ACYLTRANSFERASE INHIBITOR EISAI CO., LTD. (JP) 1997-09-16 US disclosed
US-5602252-A Tricyclic pteridinones and a process for their preparation BERLEX LABORATORIES, INC. 1997-02-11 US disclosed
CN-1122331-A Benzene, pyridine and pyrimidine derivative EISAI CO LTD (JP) 1996-05-15 CN disclosed
EP-0477778-B1 Benzene, pyridine and pyrimidine derivative EISAI CO LTD (JP) 1996-04-24 EP disclosed
US-5442060-A Treating hyperlipemia, atherosclerosis MITSUBISHI KASEI CORPORATION (JP) 1995-08-15 US disclosed
US-5397781-A Pyrimidine derivatives MOCHIDA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-03-14 US disclosed
EP-0615970-A1 Benzene, pyridine and pyrimidine derivative Eisai Co., Ltd. (JP) 1994-09-21 EP disclosed
EP-0591830-A1 Carboxamide and urea derivatives having ACAT-inhibiting activityM Mitsubishi Chemical Corporation (JP) 1994-04-13 EP disclosed
EP-0561175-A1 Pyrimidine derivatives and pharmaceutical compostions containing them MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1993-09-22 EP disclosed
CN-1060466-A Derivatives of Benzene, Pyridine and Pyrimidine EISAI CO LTD (JP) 1992-04-22 CN disclosed
EP-0477778-A2 Benzene, pyridine and pyrimidine derivative Eisai Co., Ltd. (JP) 1992-04-01 EP disclosed
EP-0429149-A1 Tricyclic pteridinones and a process for their preparation BERLEX LABORATORIES, INC. (US) 1991-05-29 EP disclosed